Veterinary Medicines

Nobilis Salenvac ETC suspension for injection for chickens

Authorised
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain DT104, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Infantis, strain A S03499-06, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain PT4, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis Salenvac ETC suspension for injection for chickens
Nobilis Salenvac ETC, Injekční suspenze
Active substance:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain DT104, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Infantis, strain A S03499-06, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain PT4, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain DT104, Inactivated
    1.00
    unit(s)
    /
    1.00
    Dose
  • Salmonella enterica, subsp. enterica, serovar Infantis, strain A S03499-06, Inactivated
    1.00
    unit(s)
    /
    1.00
    Dose
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain PT4, Inactivated
    1.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:
  • Lagedichtheidpolyethyleen (LDPE) flaconmet 1000 doses vaccin. De flacon is afgesloten met een halogeenbutyl rubber stop en een aluminium felscapsule.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/027/20-C
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0305/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 9/12/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 8/02/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."